微创治疗高血压性脑出血临床研究

目的：评价微创颅内血肿清除术对高血压性脑出血的临床疗效。方法：对78例脑出血患者随机分为治疗组38例，对照组40例，对照组应用常规内科保守治疗，治疗组在此基础上应用微创治疗，观察治疗后两组的临床疗效及并发症。结果：有效率治疗组86．以％，对照组52．50％，两组比较P＜0．01，差异有非常显著性意义，显效率治疗组52．63％，对照组30．00％，两组比较P＜0．05，差异有显著性意义．生存患者中日常生活能力及意识恢复时间，治疗组高于对照组，两组比较P＜0.01，差异有显著性意义。并发症发生率治疗组17．14％，对照组44.12％两组比较P＜0．01，差异有显著性意义。结论：微创血肿清除术治疗高血压性脑出血较单用内科保守治疗疗效好，并发症少，死亡率低，显著改善病人生活质量。

Clinical study on microlesion therapy in treating hypertensive brain hemorrhage

Object:To evaluate the clinical efficency of microlesion intracranial hematoma dissection in treating hypertensive brain hemorrhage(HBH) . Methods: 78patients were divided into two groups radomly,the control group were given the traditional therapy,while the tested group was combined with microlesion intracranial hematoma dissection. Result: the total effective rate of the tested group was 86.84%,with the complete responseof 52.63%,and that was 52.5%with CR of 30.00%in the control group,the difference was statistically significance .The incidence of complication in the tested group was 17.14%compared to 44.12% in the contral group,the death rate was 7.89%in the tested group compared to 15.00%in the contral group.the difference between them also had statistically significnce. Conclusion:Microlesion intracranial hematoma dissection combined with the tranditional therapy can increase the clinical efficency and decrease the complication,it is worthy of use in the treatment of HBH.